Antidepressant drugs for older patients on polypharmacy: a systematic review reveals best evidence for sertraline
Global Psychiatry · 2018
DOI: 10.2478/gp-2018-0005 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Global Psychiatry, 2018. Verfasst von Matej Stuhec und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Themen: Medikationssicherheit
Abstract (Originalsprache)
Objectives
There is almost no data on antidepressant prescribing in older adults treated with polypharmacy, although this population represents approximately 50% of older patients. These patients are frequently excluded from double-blind randomized controlled trials, meta-analyses and existing treatment guidelines. The main aim of this paper was to identify data on antidepressant prescribing in depressed older adults on polypharmacy using a systematic review.
Methods
Randomized controlled clinical trials (RCTs) and other clinical trials in Medline/PubMed without language limitation (-2017) were searched to identify those with older depressed patients on polypharmacy. Only elderly patients (>65 years as mean) were included. Only approved antidepressants were included.
Results
The systematic search identified 26 different clinical trials, although only one clinical open label trial with sertraline met the final inclusion criteria. This sertraline trial indicated the absence of clinically important drug-drug interactions and confirmed the effectiveness and safety of sertraline in routine clinical practice. Heterogeneity in this trial was high in almost all the categories except attrition and reporting bias.
Conclusions
Sertraline has the highest evidence level in older adults with depression on polypharmacy. According to the results of this review and due to a low number of appropriate trials, a basic understanding of psychopharmacology is the possible approach to avoid serious problematic drug combinations in these patients. Newer RCTs are also urgently needed. This is the first systematic review including patients treated with polypharmacy, and therefore, its results are important in the field of evidence-based medicine.
Zitieren
APA
Stuhec, M., & Serra-Mestres, J. (2018). Antidepressant drugs for older patients on polypharmacy: a systematic review reveals best evidence for sertraline. Global Psychiatry. https://doi.org/10.2478/gp-2018-0005
Vancouver
Stuhec M, Serra-Mestres J. Antidepressant drugs for older patients on polypharmacy: a systematic review reveals best evidence for sertraline. Global Psychiatry. 2018. doi:10.2478/gp-2018-0005
BibTeX
@article{Stuhec2018,
author = {Stuhec, Matej and Serra-Mestres, Jordi},
title = {Antidepressant drugs for older patients on polypharmacy: a systematic review reveals best evidence for sertraline},
journal = {Global Psychiatry},
year = {2018},
doi = {10.2478/gp-2018-0005}
}
EUVIMED